Normal-Sized Needles Segment to Lead Intradermal Injection Market During 2021–2028
According to our latest study on “Intradermal Injection Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Method, Application, and End User,” the market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The intradermal injection market growth is attributed to the increasing intradermal vaccination, increasing incidence of various diseases, and rising acceptance of aesthetic procedures. Additionally, strategic developments by manufacturers are likely to emerge as a significant trend in the market during the forecast period. However, the risks, complications, and dosing limitations associated with Intradermal Injections hamper the growth of the intradermal injection market.
Based on method, the intradermal injection market is segmented into normal-sized needles, short needles and without needles. The short needles are further subsegmented into intradermal microinjection, microneedle arrays and tattoo devices, while the without needles are subsegmented into intradermal liquid jet injectors, and ballistic intradermal injectors. In 2021, the normal-sized needles dominated the intradermal injection market. However, the short needles segment is expected to register the highest CAGR during the forecast period.
Normal sized needles are the conventionally used intradermal needles, which are also known as Mantoux needles and are used for performing the tuberculin sensitivity test for diagnosis of tuberculosis. As more than one third of the global population has tuberculosis, the demand of intradermal injection increasing at tremendous rate and normal size needles are majorly fulfilling this rising global demand. Currently, normal size needles of various leading companies are available in the market as the Mantoux tuberculin test is considered as standard method for detecting the TB. Ideally, the capacity of Mantoux intradermal injection is about 0.1ml, which is considered as 5 tuberculin units.
On the other hand, short needles are the advanced form of intradermal injections, which improves the accuracy of the drug delivery with comparatively less pain. The convenient nature of short needles is one of the major reason for it increasing acceptance among the global population and it is currently replacing most of the traditionally used intradermal needles. Further, the needle free injections for intradermal delivery are one of the recently developed products, which are currently emerging as ideal devices of this segment and many leading pharmaceutical companies are currently working in this segment for developing new products. Currently, intradermal liquid jet injectors and Ballistic intradermal injectors are commercially available as needle free system in most of the regions.
Recently, rapid increase in the aesthetic procedures is observed at global level and many of the leading aesthetic procedures involve the use of intradermal injections. As per the data of the Aesthetic Plastic Surgery National Databank, more than 7 million aesthetic procedures were performed in US during 2020 among which the leading segment was toxins and fillers with about 3.9 Million procedures. Neurotoxins related aesthetic procedures are the leading one and intradermal injections are mainly used for delivering various neurotoxins and ultimately increasing the demand of intradermal injections. Further, the other developing countries including Canada, UK, Germany, France etc. are also adapting the cosmetic surgeries and hence it will act as major driver for the growth of intradermal injection market.
Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices are among the leading companies operating in the intradermal injection market.
Intradermal Injection Market, by Region, 2021 (%)
Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method (Normal Sized Needles, Short Needle {Intradermal Microinjection, Microneedle Arrays, and Tattoo Devices}, and Without Needle {Intradermal Liquid Jet Devices and Ballistic Intradermal Injectors}), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)
Intradermal injection Market Stastical Report 2022, 2028
Download Free Sample
The intradermal injection market is segmented on the basis of method, application, and end user. Based on method, the market is segmented into normal-sized needles, short needles, and without needles. Based on application, the market is further segmented into tuberculin skin testing, allergy test, local aesthetics, and others. On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others.
In terms of geography, the intradermal injection market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and Rest of MEA), and South and Central America (Brazil, Argentina, and Rest of SCAM).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com